Immune Responses to Dengue and Zika Viruses—Guidance for T Cell Vaccine Development
AbstractDespite numerous efforts to identify the molecular and cellular effectors of the adaptive immunity that induce a long-lasting immunity against dengue or Zika virus infection, the specific mechanisms underlying such protective immunity remain largely unknown. One of the major challenges lies in the high level of dengue virus (DENV) seroprevalence in areas where Zika virus (ZIKV) is circulating. In the context of such a pre-existing DENV immunity that can exacerbate ZIKV infection and disease, and given the lack of appropriate treatment for ZIKV infection, there is an urgent need to develop an efficient vaccine against DENV and ZIKV. Notably, whereas several ZIKV vaccine candidates are currently in clinical trials, all these vaccine candidates have been designed to induce neutralizing antibodies as the primary mechanism of immune protection. Given the difficulty to elicit simultaneously high levels of neutralizing antibodies against the different DENV serotypes, and the potential impact of pre-existing subneutralizing antibodies induced upon DENV infection or vaccination on ZIKV infection and disease, additional or alternative strategies to enhance vaccine efficacy, through T cell immunity, are now being considered. In this review, we summarize recent discoveries about cross-reactive B and T cell responses against DENV and ZIKV and propose guidelines for the development of safe and efficient T cell vaccines targeting both viruses. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Roth, C.; Delgado, F.G.; Simon-Lorière, E.; Sakuntabhai, A. Immune Responses to Dengue and Zika Viruses—Guidance for T Cell Vaccine Development. Int. J. Environ. Res. Public Health 2018, 15, 385.
Roth C, Delgado FG, Simon-Lorière E, Sakuntabhai A. Immune Responses to Dengue and Zika Viruses—Guidance for T Cell Vaccine Development. International Journal of Environmental Research and Public Health. 2018; 15(2):385.Chicago/Turabian Style
Roth, Claude; Delgado, Félix G.; Simon-Lorière, Etienne; Sakuntabhai, Anavaj. 2018. "Immune Responses to Dengue and Zika Viruses—Guidance for T Cell Vaccine Development." Int. J. Environ. Res. Public Health 15, no. 2: 385.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.